This new two year part-time Masters programme in Vascular & Endovascular Surgery, taught entirely online, is offered by the Royal College of Surgeons of Edinburgh and the University of Edinburgh, and leads to the degree of Master of Surgery (ChM).
Based on the UK Intercollegiate Surgical Curriculum, the programme provides advanced training for surgeons preparing for the intercollegiate fellowship examination and approaching independent surgical practice.
The ChM provides advanced training for surgeons preparing for the intercollegiate fellowship examination and approaching consultancy.
On completion of this programme students will be able to:
The programme is taught entirely online. Students are supported by asynchronous discussion with e-tutors (all leading clinicians in their field) and have access to a large learning resource, including subscriptions to key online books and journals.
Our award-winning interactive online learning technology enables you to communicate with our highly qualified teaching staff from the comfort of your own home or workplace.
Online students not only have access to Edinburgh’s excellent resources, but also become part of a supportive online community, bringing together students and tutors from around the world.
The programme runs on a semester basis over 2-4 years and involves approximately 10-15 hours of study each week, in a flexible modular manner.
The programme is delivered using a purpose-built learning environment that supports a variety of learning styles, and allows students flexibility in their study patterns.
Courses within the programme are also offered as Continuous Professional Development (CPD).
Core modules in each area of vascular and endovascular surgery are aligned to the ISPC Curriculum. These are taught and assessed using a clinical problem-based approach, supported by systems-based review of the course material, which should mirror ‘in-the-workplace’ activities.
Component courses include Principles of Vascular Practice, Aneurysms, Venous & Lymphatic Disorders, Vascular Trauma and Principles of Endovascular Practice. Each semester, courses are taught concurrently such that a student may be engaged in 5-6 asynchronous discussions at any one time (one per course). Students will spent 10-15 hours on programme-related study each week (activities include reading the discussion thread, reading around the topic, contributing to the discussion).
Knowledge and understanding will be assessed in the second year, following completion of core modules, with a formal written examination (MCQs and EMIs) that will replicate the trainees upcoming exit exams.
Academic modules will explore research and teaching methodology, whilst enabling students to develop the ability to analyse published evidence and enhance their interactive and written clinical communication skills.
Students are required to complete a dissertation based on original research or a systematic review in a relevant area of work. Alternatively, an individual with a number of peer-reviewed journal publications may undertake an academic critique of their work.
The programme will offer an alternative to clinical / laboratory research training for those students who do not wish to take time out of surgical training. It will develop the trainee's academic portfolio and facilitate surgical research projects essential to a research active career.
The ChM programme is designed to follow the ISCP curriculum and prepare the advanced surgical trainee for their exit professional examinations allowing appointment as an independently practising surgeon.
The award of ChM will highlight the trainee's commitment to continual professional development and will ensure a competitive edge when applying for consultant positions.
The Ultrasound in Emergency and Critical Care PG Cert will appeal to a wide range of healthcare professionals who wish to develop focused ultrasound skills as an extension of their clinical practice. This course offers a combination of work-based learning and lectures that cover the underlying theoretical concepts of ultrasound scanning and clinical applications of Focused Assessment with Sonography in Trauma (FAST), Assessment of the Abdominal Aorta for Aneurysm (AAA), Focused Echocardiography in Life Support (ELS) and Ultrasound Guided Vascular Access (VA). In addition basic assessment of Deep Vein Thrombosis (DVT) and emergency assessment of the female pelvis will be covered.
The course is an intensive and enjoyable training experience which has been designed to bring together the core elements of RCEM with additional features of other point-of-care areas of ultrasound that provide decision making tools to guide patient triage.
The course focuses on the theoretical areas required for understanding the principles of ultrasound followed by intense practical sessions. The practical areas will have clear objectives leading to competence assessment and preparation for use within a clinical setting and progression to the Level 2.
You are assessed through a combination of:
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they may change if the course modules change.
The course is primarily taught at the King’s College London St Thomas’, Waterloo and Guy’s campuses. Please note that locations are determined by where each module is taught and may vary depending on the optional modules you select.
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.